Los Contratos por diferencia («CFD») son instrumentos complejos que comportan un riesgo elevado de pérdidas rápidas debido al apalancamiento. El 74% de las cuentas de inversores particulares pierde dinero al operar CFD con este proveedor. Debe considerar si comprende el funcionamiento de los CFD y si puede permitirse asumir un riesgo elevado de perder su dinero.

Close

Opere MerckCo USA MRK

MerckCo gráfico en tiempo real

Fundamentales del instrumento

Weekly Search
Weekly
Daily
Fecha Cerrar Cambio Cambio del % Apertura Alto Bajo

Últimas noticias

Closing 2024
2024 Dec 26, 17:00

Adelanto semanal: Cierre de 2024 y primeros datos económicos de 2025

Índices Forex
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Adelanto semanal: Última semana completa de 2024 en los mercados financieros

Índices Forex
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Adelanto semanal: Tasas en EE. UU. e inflación en Europa determinarán el curso del mercado

Forex Índices
Dyogenes Diniz 2024 Dec 05, 16:00

Adelanto semanal: La inflación y las tasas de interés sacudirán los mercados esta semana

Forex Índices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Adelanto semanal:  El empleo en EE. UU. marcará probablemente el sentimiento de mercado esta semana.

Forex Índices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Adelanto semanal:  Inflación de la Eurozona podría confirmar el recorte del BCE en diciembre

Forex Índices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Adelanto semanal: El rally tecnológico dependerá de los resultados de Nvidia

Forex Índices
Markets.com Support Team 2024 Nov 07, 16:00

Adelanto semanal: «Trump Trade», datos de inflación, resultados de Disney

Forex Índices

Información

Spread

0.48

Spread (%)

0.6217 %

Apalancamiento

1:5

Interés a un día (Compra)

-0.0597 %

Interés a un día (Venta)

-0.0292 %

Divisa

USD

Horarios de los mercados

Markets closed

Viernes

13:31 - 19:59

Lunes

13:31-19:59

Martes

13:31-19:59

Miércoles

13:31-19:59

Jueves

13:31-19:59

Análisis y estadísticas

Apertura

---

Cierre anterior

---

Máximo/mínimo de 52 semanas

--- – ---

Capitalización de mercado

199247757312

Acciones en circulación

2516389888

Fecha de ganancias (próxima)

2021-06-03

Rentabilidad por div. 

2025-04-07

Fecha exdividendo

2025-03-17

Tasa de dividendo anual anticipado

3.24

Rendimiento de dividendo anual anticipado

0.0409

GPA

6.74

Conoce más sobre este instrumento

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Instrumentos relacionados

Activo
Vender
Comprar
Cambio del %
Instrumentos relacionados
Trustpilot
SettingsRequest history38.1.18PHP Version30.69msRequest Duration2MBMemory UsageGET csrf
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
controller_action
Closure
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
action_name
controller_action
Closure
uri
GET csrf
file
routes/web.php:26-30
middleware
web
duration
31.25ms
peak_memory
2MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
0 of 0
array:14 [ "cookie" => array:1 [ 0 => "mktv4_ip_override=es-es; mktloc=eyJpdiI6InZZRllkcEZQZVJpK0o4MEw3ang1UUE9PSIsInZhbHVlIjoibGF3Qzc2d2VBa3BCS1ptbGI2ZDVjVS9ZNW8wOFc4eFQzQlo5NHFGVklXYjN3VEhmV0E5YlRoZEY4dnJWWUIwMiIsIm1hYyI6IjQ3YmNjYjIxNzdkZWZlNDJkNmRhZTU0OTFlN2QxNGI3NDE3Y2NjM2U5ZmI3OGJjNjEyZGRiZmY3OGFkMDFiNDIiLCJ0YWciOiIifQ%3D%3D; firstURL=https://web-qa.staging.markets.com/es-es/instrument/vipshop/; lastURL=https://web-qa.staging.markets.com/es-es/instrument/vipshop/; intent_group=%252Fes-es%252Finstrument%252Fmerckco%252F; intent_instrument=merckco; XSRF-TOKEN=eyJpdiI6Im9rQWcvMkhuOVdqK1lNeVEzWkt4Snc9PSIsInZhbHVlIjoibGtxNDNyQytOdXRzQjBjMkVmbDJXYVNTTUFpMTRVT2hYem1Vay9DdGlBeUtjK3lNVUJqQ3dMMXpxUXRkSzc3SEdlVzdMa3ZTWEJkUkhnWjBEZ2MxdVFHaFhzbTQ0SXpYNFdMazJjR25PV0VyWkRYWHdZVVVldkcwZHc5Nm41eWkiLCJtYWMiOiJlOGZkZjFmMWRiMWNmOGUwNDdjMjE0N2RjY2E2Y2QwODI1N2ZhMzM3MzMwMGE3Y2YwMTQ4YzAzYzk0MDA4NDI3IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImZqVEJoVUxFV0RLOWVDcjdSazVtNXc9PSIsInZhbHVlIjoiTU81WUtJUTg3QlJoRXJhVXFIQ3BCVE9STHJ1a1dReThmOFlDSC8wZ3h2U0JCRmZmUVhGMEtKYnRiWDdxOFBMeHF5cWdsUkd4c1NhQ3ArSmFUS3E0Y0pMTVZGUWFkTGgrQktuc29zbTZBbmFLVklvL1JLN01yVkFqTllaMWx2TEEiLCJtYWMiOiI2M2MzOGZmYmI3YzQzMmFkMDg4ZDg3MTFlZDY0MWY1NzZjMDU0NDY4ZWEzNjdiYzA2ZGFlYWU5YzkxMzVhM2IzIiwidGFnIjoiIn0%3Dmktv4_ip_override=es-es; mktloc=eyJpdiI6InZZRllkcEZQZVJpK0o4MEw3ang1UUE9PSIsInZhbHVlIjoibGF3Qzc2d2VBa3BCS1ptbGI2ZDVjVS9ZNW8wOFc4eFQzQlo5NHFGVklXYjN3VEhmV0E5YlRo" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "empty" ] "sec-fetch-mode" => array:1 [ 0 => "cors" ] "sec-fetch-site" => array:1 [ 0 => "same-origin" ] "accept" => array:1 [ 0 => "*/*" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "web-qa.staging.markets.com" ] ]
request_cookies
0 of 0
array:8 [ "mktv4_ip_override" => null "mktloc" => "us,us" "firstURL" => null "lastURL" => null "intent_group" => null "intent_instrument" => null "XSRF-TOKEN" => "kQnHhzZbTqO5oR2wikOde3zPErOgknKiMsJzHcwo" "laravel_session" => "aHT04DZwg7qJFQEkRHSE95mqItd0ZBSHBrhhMQa4" ]
response_headers
0 of 0
array:3 [ "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Mon, 14 Apr 2025 05:18:25 GMT" ] "content-type" => array:1 [ 0 => "application/json" ] ]
session_attributes
0 of 0
array:4 [ "_token" => "kQnHhzZbTqO5oR2wikOde3zPErOgknKiMsJzHcwo" "PHPDEBUGBAR_STACK_DATA" => [] "_previous" => array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/es/ITX:SIBE?scheme=light" ] "_flash" => array:2 [ "old" => [] "new" => [] ] ]
    • Booting (21.13ms)time
    • Application (9.55ms)time
    • Routing (492μs)
    • 1 x Booting (68.86%)
      21.13ms
      1 x Application (31.1%)
      9.55ms
      1 x Routing (1.6%)
      492μs
      0 templates were rendered
        uri
        GET csrf
        middleware
        web
        uses
        Closure(Request $request) {#347 class: "Illuminate\Routing\RouteFileRegistrar" this: Illuminate\Routing\RouteFileRegistrar {#344 …} file: "/var/www/website/qa/laravel/routes/web.php" line: "26 to 30" }
        file
        routes/web.php:26-30
        0 statements were executed0μs
              _token
              kQnHhzZbTqO5oR2wikOde3zPErOgknKiMsJzHcwo
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/es/ITX:SIBE?schem...
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-14 05:18:24GET/es-es/instrument/merckco/1067
              #22025-04-14 05:18:25GET/params/ (ajax)
              #32025-04-14 05:18:25GET/csrf/ (ajax)